Bosh sahifa2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Yopilish kursi
14,80 $
Kunlik diapazon
14,70 $ - 15,10 $
Yillik diapazon
11,52 $ - 19,50 $
Bozor kapitalizatsiyasi
62,83 mlrd HKD
Oʻrtacha hajm
5,35 mln
Narx/foyda
20,32
Dividend daromadliligi
-
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 10,16 mlrd | -5,09% |
Joriy xarajat | 4,25 mlrd | -14,46% |
Sof foyda | 759,24 mln | 635,70% |
Sof foyda marjasi | 7,48 | 679,17% |
Har bir ulushga tushum | — | — |
EBITDA | 1,00 mlrd | 115,25% |
Amaldagi soliq stavkasi | 9,46% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 16,12 mlrd | 3,45% |
Jami aktivlari | 117,46 mlrd | 3,52% |
Jami passivlari | 57,53 mlrd | 1,18% |
Umumiy kapital | 59,93 mlrd | — |
Tarqatilgan aksiyalar | 2,66 mlrd | — |
Narxi/balansdagi bahosi | 0,83 | — |
Aktivlardan daromad | 0,79% | — |
Kapitaldan daromad | 0,96% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 759,24 mln | 635,70% |
Operatsiyalardan naqd pul | 1,49 mlrd | 56,45% |
Sarmoyadan naqd pul | -1,17 mlrd | -119,37% |
Moliyadan naqd pul | -500,30 mln | 46,76% |
Naqd pulning sof oʻzgarishi | -85,94 mln | 85,18% |
Boʻsh pul | 2,92 mlrd | 9,19% |
Haqida
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Tashkil etilgan
1994
Sayt
Xodimlar soni
40 557
